Browse CATs

Browse CATs  internal medicine  haematology  anticoagulation

Economics Prognosis Therapy Bleeding Heparin LMWH Warfarin

Anticoagulation a multicomponent intervention does not clearly reduce major bleeding in the elderly Level of evidence 1b- Expiry Date October 2003 Anticoagulation self-management of INR was as effective as anticoagulation clinic-based care. Level of evidence 1b Expiry Date June 2003 Anticoagulation primary-care based management was as safe and effective as hospital-based management. Level of evidence 1b Expiry Date October 2003 Anticoagulation an age-adjusted warfarin loading regimen was better than the Fennerty regimen Level of evidence 2b Expiry Date June 2004 Anticoagulation more patients on a five day anticoagulation course died than on a ten day one. Level of evidence 1b Expiry Date June 2003 Anticoagulation a flexible warfarin dosing regimen may be used. Level of evidence 4 Expiry Date June 2002 Anticoagulation biological prosthetic heart valve: fewer bleeds on less intensive INR. Level of evidence 1b Expiry Date June 2003 Anticoagulation patients on warfarin felt as healthy as patients who were not. Level of evidence 1b Expiry Date June 2003 Anticoagulation guidelines and consultation reduced bleeds and venous thromboembolism. Level of evidence 1b Expiry Date June 2003 Anticoagulation starting warfarin within 48 hours of heparin shortened hospital stay. Level of evidence 1b Expiry Date June 2003 Anticoagulation computer-dosing of warfarin meant shorter time to a stable therapeutic INR. Level of evidence 1b Expiry Date July 2003 Anticoagulation reducing the loading dose of warfarin limited over anticoagulation. Level of evidence 1b Expiry Date December 2003 Anticoagulation a 5 mg loading dose was more successful than 10 mg Level of evidence 1b Expiry Date October 2003 Antiphospholipid-antibody syndrome warfarin reduced thrombosis. Level of evidence 4 Expiry Date June 2003 Atrial fibrillation warfarin reduces the risk of stroke and death. Level of evidence 1a Expiry Date June 2003 Atrial fibrillation fewer strokes on adjusted-dose warfarin than fixed dose plus aspirin. Level of evidence 1b Expiry Date June 2002 Atrial fibrillation more bleeds occurred on warfarin than aspirin. Level of evidence 1b Expiry Date June 2003 Deep vein thrombosis first episode: fewer recurrences occurred on six months of warfarin compared with six weeks. Level of evidence 1b Expiry Date September 2003 Deep vein thrombosis no clear difference between nadroparin and acenocoumarol long-term Level of evidence 1b Expiry Date November 2003 Deep vein thrombosis three months anticoagulation was not clearly better than four weeks Level of evidence 1b- Expiry Date May 2003 Deep vein thrombosis calf: three months of anticoagulation reduced recurrences. Level of evidence 1b Expiry Date March 2003 Stroke carotid endarterectomy and warfarin were cost-effective. Level of evidence 1b Expiry Date January 2003 Stroke no clear benefit from anticoagulation if there is no embolic source Level of evidence 1a Expiry Date November 2003 Stroke immediate anticoagulation had no clear effect on recurrent embolic stroke. Level of evidence 1b- Expiry Date June 2003 Stroke indobufen was not clearly better than warfarin. Level of evidence 1b- Expiry Date October 2003 Unstable angina moderate intensity warfarin decreases rehospitalisation with unstable angina. Level of evidence 1b Expiry Date January 2003 Venous thromboembolism idiopathic: indefinite anticoagulation reduced recurrent episodes. Level of evidence 1b Expiry Date October 2003 Venous thromboembolism indefinite warfarin decreased recurrence. Level of evidence 1b Expiry Date May 2003 Venous thromboembolism indefinite warfarin decreased recurrence. Level of evidence 1b Expiry Date September 2003 Venous thromboembolism fewer deaths and bleeds on LMWH compared with heparin. Level of evidence 1a Expiry Date May 2003 Warfarin many food and drugs interact. Level of evidence 3a Expiry Date December 2003